• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

儿童和青少年血管性血友病的当前治疗方法

Current therapy in children and adolescents with von Willebrand disease.

作者信息

Buga-Corbu I, Arion C

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest.

"I. C. Fundeni" Pediatric Clinic,"Carol Davila" University of Medicine and Pharmacy, Bucharest.

出版信息

J Med Life. 2014 Jun 15;7(2):264-9. Epub 2014 Jun 25.

PMID:25408737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4197504/
Abstract

The article represents a review of recent data about the therapy of von Willebrand disease in children and adolescents (hereditary as well as acquired forms of the disease). The treatment of bleeding events in these patients, the indications in different subtypes, and the future lines of research are mentioned.

摘要

本文综述了有关儿童和青少年血管性血友病（包括遗传性和获得性）治疗的最新数据。文中提及了这些患者出血事件的治疗方法、不同亚型的治疗指征以及未来的研究方向。

相似文献

1
Current therapy in children and adolescents with von Willebrand disease.儿童和青少年血管性血友病的当前治疗方法
J Med Life. 2014 Jun 15;7(2):264-9. Epub 2014 Jun 25.
2
Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.血管性血友病——手术中的“注意事项”与“禁忌事项”
Eur J Haematol. 2017 Feb;98(2):121-127. doi: 10.1111/ejh.12809. Epub 2016 Oct 14.
3
Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.在手术环境中使用去氨加压素和血管性血友病因子-凝血因子VIII浓缩物治疗1型、2型和3型血管性血友病患者。
Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8.
4
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
5
Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.因血管性血友病因子突变C1130F杂合性导致的1型血管性血友病女性的妊娠情况。
Thromb Haemost. 2000 Aug;84(2):351-2.
6
How I treat patients with von Willebrand disease.我如何治疗血管性血友病患者。
Blood. 2001 Apr 1;97(7):1915-9. doi: 10.1182/blood.v97.7.1915.
7
Advances in the diagnosis and management of von Willebrand disease.血管性血友病诊断与治疗的进展
Hematology. 2006 Aug;11(4):219-25. doi: 10.1080/10245330600841311.
8
Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience.威尔特（Wilate）在47例血管性血友病患儿中的应用：北伦敦儿科血友病网络的经验
Haemophilia. 2015 Jan;21(1):e44-50. doi: 10.1111/hae.12497. Epub 2014 Aug 12.
9
[Inborn and acquired von Willebrand disease].[先天性和获得性血管性血友病]
Hamostaseologie. 2008 Dec;28(5):312-9.
10
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.1型、2型和3型血管性血友病患者出血治疗和预防中静脉注射去氨加压素及血管性血友病因子/凝血因子VIII浓缩物的评估指南
Semin Thromb Hemost. 2006 Sep;32(6):636-45. doi: 10.1055/s-2006-949669.

本文引用的文献

1
Application of UKHCDO 2004 guidelines in type 1 von Willebrand Disease--a single centre paediatric experience of the implications of altered or removed diagnosis.英国血友病儿童诊疗规范 2004 年版在 1 型血管性血友病中的应用——改变或去除诊断对单中心儿科的影响的经验
Haemophilia. 2011 May;17(3):522-6. doi: 10.1111/j.1365-2516.2010.02452.x. Epub 2011 Mar 4.
2
von Willebrand disease in the pediatric and adolescent population.儿科和青少年人群中的血管性血友病
J Pediatr Adolesc Gynecol. 2010 Dec;23(6 Suppl):S3-10. doi: 10.1016/j.jpag.2010.08.005.
3
Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.利用表型和分子数据优化血管性血友病的治疗。
Hematology Am Soc Hematol Educ Program. 2009:113-23. doi: 10.1182/asheducation-2009.1.113.
4
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.血管性血友病因子/凝血因子VIII浓缩物在血管性血友病治疗中的应用
Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570.
5
Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.在手术环境中使用去氨加压素和血管性血友病因子-凝血因子VIII浓缩物治疗1型、2型和3型血管性血友病患者。
Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8.
6
Evidence-based recommendations on the treatment of von Willebrand disease in Italy.意大利关于血管性血友病治疗的循证推荐意见。
Blood Transfus. 2009 Apr;7(2):117-26. doi: 10.2450/2008.0052-08.
7
Von Willebrand disease: screening, diagnosis, and management.血管性血友病：筛查、诊断与管理
Aesthet Surg J. 2008 Mar-Apr;28(2):189-94. doi: 10.1016/j.asj.2007.12.002.
8
Type 1 von Willebrand disease: application of emerging data to clinical practice.1型血管性血友病：新兴数据在临床实践中的应用
Haemophilia. 2008 Jul;14(4):685-96. doi: 10.1111/j.1365-2516.2008.01757.x. Epub 2008 May 23.
9
von Willebrand disease update: diagnostic and treatment dilemmas.血管性血友病最新进展：诊断与治疗难题
Haemophilia. 2008 Jul;14 Suppl 3:56-61. doi: 10.1111/j.1365-2516.2008.01713.x.
10
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).血管性血友病（VWD）：基于证据的诊断和管理指南，美国国立心肺血液研究所（NHLBI）专家小组报告
Haemophilia. 2008 Mar;14(2):171-232. doi: 10.1111/j.1365-2516.2007.01643.x.